
WALTHAM, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a regenerative medicine ...

Moffitt Cancer Center collaborators to present next-generation chimeric antigen receptor T-cell (CAR T) technology ...
Click to continue to site. Closing